BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Veloxis Pharmaceuticals A/S 

Kogle Allé 4

  DK-2970  Hørsholm  Denmark
Phone: 457-033-3300 Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Veloxis Pharmaceuticals A/S (VELO) Announces That It Has Filed An Action Against The FDA, Seeking An Order Requiring FDA To Grant Final Approval To Envarsus XR 12/17/2014 9:47:23 AM
Veloxis Pharmaceuticals A/S (VELO) Announces Publication Of Phase 3 Study Of Once Daily Envarsus® XR Demonstrating Non-Inferiority Vs. Twice-Daily Tacrolimus In De Novo Kidney Transplant Patients 11/17/2014 10:14:16 AM
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Nine Months Of 2014 And Improves The Full Year Outlook 11/12/2014 10:04:20 AM
Veloxis Pharmaceuticals A/S (VELO) Announces Tentative Approval Of Envarsus® XR 10/31/2014 8:17:37 AM
Veloxis Pharmaceuticals A/S (VELO) Is Implementing Cegedim Relationship Management Mobile Intelligence CRM And Support Services To Empower Diverse Field Users 10/15/2014 1:43:16 PM
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Six Months Of 2014 8/21/2014 7:56:07 AM
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® Receives European Marketing Authorization For Treatment Of Both Kidney And Liver Transplant Patients 7/28/2014 7:44:37 AM
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®) 6/30/2014 8:32:36 AM
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®) 6/30/2014 8:06:09 AM
Veloxis Pharmaceuticals A/S (VELO) Announces Positive Two-Year Results From Pivotal Phase 3 Study Of Envarsus® XR (Tacrolimus Extended-Release Tablets) In De Novo Kidney Transplant Patients 6/23/2014 10:50:42 AM
12345678